Definitive Contract 75D30123C17984
Award Date
9/26/23
Potential Completion Date
4/22/25
Potential Value
$39M
Federal Agency
CDC Pittsburgh
Awardee
Verily Life Sciences LLC
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
9
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Centers for Disease Control and Prevention (CDC) awarded a $41,290,502.86 firm-fixed-price definitive contract to Verily Life Sciences LLC, doing business as G L S, for wastewater surveillance testing. The contract has an ultimate completion date of August 6, 2026 and was awarded on January 12, 2024 without any set-aside designation. Verily Life Sciences, a subsidiary of Alphabet Inc., specializes in collecting, organizing, and activating health data, and has provided wastewater surveillance...
This is a definitive contract awarded by the National Institute on Aging, a civilian agency, to Verily Life Sciences LLC, a for-profit limited liability company. The contract, worth $750,000.00, is for firm-fixed-price wastewater surveillance testing services to support disease monitoring programs, particularly for COVID-19 and monkeypox. The contract does not have a set-aside designation, indicating it was competed openly. The period of performance extends through May 1, 2025, demonstrating the...
The Centers for Disease Control and Prevention awarded a $31 million firm fixed price contract to Biobot Analytics Inc. to provide commercial wastewater surveillance testing services in support of the National Wastewater Surveillance System. Under the terms of the contract, Biobot Analytics will quantitatively test wastewater samples twice weekly for SARS-CoV-2 and sequence qualifying samples over an 11-month period from April 2022 through February 2023. The contract is set aside for small...
The Centers for Disease Control and Prevention (CDC) awarded a $4.2 million definitive contract to Luminultra Technologies Inc. to provide Coronavirus (COVID-19) wastewater sampling services. The firm fixed price contract will be performed in Halethorpe, Maryland from December 21, 2021 through June 15, 2022. As a total small business set aside, Luminultra Technologies Inc. will serve as the prime contractor to support the CDC's National Interest Action efforts to monitor COVID-19 levels in...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $681,553.26 firm fixed-price definitive contract to Aquavitas, LLC, a for-profit limited liability company, for genomic sequencing of wastewater samples and analysis to detect the presence of the SARS-CoV-2 virus. The contract, which does not have a set-aside designation, has a completion date of February 14, 2022 and was awarded on September 24, 2021. The place of performance is Scottsdale, Arizona....
This federal contract award, valued at $1,104,069.00, was issued by the Centers for Disease Control and Prevention (CDC) to the University of California, Berkeley (UC Berkeley) to evaluate robust and standardizable methods for wastewater surveillance of pathogens and antibiotic resistance. The contract is a firm fixed-price definitive contract with a completion date of April 22, 2025. The work does not have a set-aside designation. Under this award, UC Berkeley will oversee the overall...
The Centers for Disease Control and Prevention (CDC) awarded a $76,575,638.04 firm-fixed-price contract to Ginkgo Bioworks, Inc., a Boston-based biotechnology company, to conduct genomic testing and surveillance of SARS-CoV-2 at five major U.S. international airports. The contract, which runs through March 21, 2025, requires Ginkgo Bioworks to collect a minimum of 483,000 biological samples per year from international travelers and perform on-site reverse transcription polymerase chain...
This is a firm fixed price purchase order (contract) awarded by the Defense Health Agency to Biobot Analytics Inc., a self-certified small disadvantaged business, to provide SARS-COV-2 analytical services. The contract is valued at $129,600.00 and has a completion date of March 13, 2025. The original solicitation was set aside for total small business and required the contractor to provide ribonucleic acid (RNA) virus detection using quantitative polymerase chain reaction (qPCR) and reverse...
The Centers for Disease Control and Prevention (CDC) awarded GT Molecular, Inc., doing business as GT Molecular LLC, a $1,665,445.00 firm-fixed-price contract to develop, optimize, and validate a portfolio of molecular testing assays for the National Wastewater Surveillance System (NWSS). This 5-year contract, with a 12-month base period and four 12-month option periods, is set aside for small businesses. GT Molecular, a minority-owned small disadvantaged business, will provide digital PCR-based...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a purchase order contract to Soller Environmental, LLC, a small consulting firm, for wastewater surveillance services. The $134,985 time and materials contract supports COVID-19 monitoring efforts through wastewater surveillance modeling. As a subcontractor, Soller Environmental has also provided toxicological and microbial support services to the Environmental Protection Agency's Health and Ecological...